EU regulator says Johnson & Johnson vaccine benefits outweigh risks, shipments to resume in Europe
Johnson & Johnson is set to resume shipments of its COVID-19 vaccine in Europe as the pause in the U.S. continues.
The European Medicines Agency on Tuesday said that "unusual blood clots" should be "listed as very rare side effects" of Johnson and Johnson's COVID-19 vaccine, but it determined the vaccine's benefits "outweigh the risks of side effects," Axios and The New York Times report.
The agency, after reviewing eight cases of rare blood clots among the millions of people in the United States who received the Johnson & Johnson vaccine, found a "possible link" between the vaccine and the blood clots, but it said the "risk of having this side effect is very low."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Healthcare professionals and people who will receive the vaccine should be aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within three weeks of vaccination," the agency also said.
U.S. health officials last week called for a pause of the Johnson & Johnson vaccine while they examined these rare blood clotting cases. Johnson & Johnson says it will now resume shipment of its vaccine in the European Union, Norway, and Iceland. Meanwhile, the Times notes that an expert panel advising the Centers for Disease Control and Prevention on the Johnson & Johnson vaccine is set to meet later this week, and Dr. Anthony Fauci has predicted the vaccine's pause won't extend beyond this Friday.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
The issue of women and conscription
Under the radar Ukraine military adviser hints at widening draft to women, as other countries weigh defence options amid global insecurity
By Harriet Marsden, The Week UK Published
-
AI is causing concern among the LGBTQ community
In the Spotlight One critic believes that AI will 'always fail LGBTQ people'
By Justin Klawans, The Week US Published
-
'Modern presidents exercise power undreamed of by the Founding Fathers'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published